T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients (Q58449860)

From Wikidata

Jump to navigation Jump to search

scientific article published on 08 February 2012

Language	Label	Description	Also known as
English	T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients	scientific article published on 08 February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Robbie Majzner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Deirdre Duffy

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Janet Ayello

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Monica Bhatia

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Diane George

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Prakash Satwani

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lauren Harrison

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Erin Morris

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mildred Semidei-Pomales

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Joseph Schwartz

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Bachir Alobeid

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lee Ann Baxter-Lowe

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Angela M Ricci

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Judith S Jacobson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Carmella Van de Ven

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

James H Garvin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mitchell S Cairo

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

0 references

publication date

8 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

157

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

205-219

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Haploidentical SCT in children: an update and future perspectives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Long-term outcome after haploidentical stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Haploidentical stem cell transplantation for children with acute leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09048.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2012.09048.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22313507%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58449860&oldid=2089019259"